Literature DB >> 10221955

Statistics notes. Treatment allocation in controlled trials: why randomise?

D G Altman1, J M Bland.   

Abstract

Mesh：

Year:  1999        PMID： 10221955      PMCID： PMC1115595          DOI： 10.1136/bmj.318.7192.1209

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  7 in total

1.  Randomisation.

Authors:  D G Altman
Journal:  BMJ       Date:  1991-06-22

2.  STREPTOMYCIN treatment of pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1948-10-30

3.  Why we need observational studies to evaluate the effectiveness of health care.

Authors:  N Black
Journal:  BMJ       Date:  1996-05-11

4.  Improving the quality of reporting of randomized controlled trials. The CONSORT statement.

Authors:  C Begg; M Cho; S Eastwood; R Horton; D Moher; I Olkin; R Pitkin; D Rennie; K F Schulz; D Simel; D F Stroup
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

5.  Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group.

Authors: 
Journal:  Lancet       Date:  1991-07-20       Impact factor: 79.321

6.  Randomized versus historical controls for clinical trials.

Authors:  H Sacks; T C Chalmers; H Smith
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

7.  Possible prevention of neural-tube defects by periconceptional vitamin supplementation.

Authors:  R W Smithells; S Sheppard; C J Schorah; M J Seller; N C Nevin; R Harris; A P Read; D W Fielding
Journal:  Lancet       Date:  1980-02-16       Impact factor: 79.321
  7 in total
  77 in total

1.  Is recruitment more difficult with a placebo arm in RCTs? Methodological issues will have affected results.

Authors:  L Forbes; S Chinn; J Figueroa-Muñoz; P Seed
Journal:  BMJ       Date:  1999-09-25

2.  Why transition from alternation to randomisation in clinical trials was made.

Authors:  I Chalmers
Journal:  BMJ       Date:  1999-11-20

Review 3.  How to randomise.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1999-09-11

Review 4.  Systematic reviews in health care: Assessing the quality of controlled clinical trials.

Authors:  P Jüni; D G Altman; M Egger
Journal:  BMJ       Date:  2001-07-07

Review 5.  Statistics notes: Concealing treatment allocation in randomised trials.

Authors:  D G Altman; K F Schulz
Journal:  BMJ       Date:  2001-08-25

6.  Methodological characteristics of academic clinical drug trials--a retrospective cohort study of applications to the Danish Medicines Agency 1993-2005.

Authors:  Louise Berendt; Cecilia Håkansson; Karin F Bach; Per B Andreasen; Lene G Petersen; Elin Andersen; Henrik E Poulsen; Kim Dalhoff
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

7.  Taking immunosuppressive medications effectively (TIMELink): a pilot randomized controlled trial in adult kidney transplant recipients.

Authors:  Cynthia Russell; Vicki Conn; Catherine Ashbaugh; Richard Madsen; Mark Wakefield; Andrew Webb; Deanna Coffey; Leanne Peace
Journal:  Clin Transplant       Date:  2010-11-16       Impact factor: 2.863

Review 8.  Coagulopathy and transfusion strategies in trauma. Overwhelmed by literature, supported by weak evidence.

Authors:  Daniele Poole
Journal:  Blood Transfus       Date:  2015-11-20       Impact factor: 3.443

Review 9.  Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding.

Authors:  Muhammad Mamdani; Kathy Sykora; Ping Li; Sharon-Lise T Normand; David L Streiner; Peter C Austin; Paula A Rochon; Geoffrey M Anderson
Journal:  BMJ       Date:  2005-04-23

10.  An adapted mindfulness-based stress reduction program for elders in a continuing care retirement community: quantitative and qualitative results from a pilot randomized controlled trial.

Authors:  Aleezé S Moss; Diane K Reibel; Jeffrey M Greeson; Anjali Thapar; Rebecca Bubb; Jacqueline Salmon; Andrew B Newberg
Journal:  J Appl Gerontol       Date:  2014-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.